Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
CanadaIPO:
05 May 2014Website:
http://www.inmedpharma.comNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 104 min agoDividend
Analysts recommendations
Institutional Ownership
INM Latest News
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced the Company will be presenting at the upcoming Emerging Growth Conference scheduled for June 12-13, 2024. InMed's CEO, Mr.
InMed Pharmaceuticals (NASDAQ: INM ) stock is falling on Wednesday after the pharmaceutical company's shares underwent a massive rally on Tuesday! INM stock was up 70.5% when normal trading hours ended on Tuesday.
Investors have seen some impressive moves in recent days in the world of micro-cap biotech stocks. Today, InMed (NASDAQ: INM ) is among the leading gainers in the market, surging more than 110% as of this writing.
What type of business is InMed Pharmaceuticals?
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
What sector is InMed Pharmaceuticals in?
InMed Pharmaceuticals is in the Healthcare sector
What industry is InMed Pharmaceuticals in?
InMed Pharmaceuticals is in the Biotechnology industry
What country is InMed Pharmaceuticals from?
InMed Pharmaceuticals is headquartered in Canada
When did InMed Pharmaceuticals go public?
InMed Pharmaceuticals initial public offering (IPO) was on 05 May 2014
What is InMed Pharmaceuticals website?
https://www.inmedpharma.com
Is InMed Pharmaceuticals in the S&P 500?
No, InMed Pharmaceuticals is not included in the S&P 500 index
Is InMed Pharmaceuticals in the NASDAQ 100?
No, InMed Pharmaceuticals is not included in the NASDAQ 100 index
Is InMed Pharmaceuticals in the Dow Jones?
No, InMed Pharmaceuticals is not included in the Dow Jones index
When does InMed Pharmaceuticals report earnings?
The next expected earnings date for InMed Pharmaceuticals is 15 August 2024